ADVM
Price
$2.75
Change
+$0.33 (+13.64%)
Updated
Jun 6, 01:41 PM (EDT)
Capitalization
50.66M
KURA
Price
$6.71
Change
+$0.15 (+2.28%)
Updated
Jun 6, 10:44 AM (EDT)
Capitalization
568.8M
55 days until earnings call
Interact to see
Advertisement

ADVM vs KURA

Header iconADVM vs KURA Comparison
Open Charts ADVM vs KURABanner chart's image
Adverum Biotechnologies
Price$2.75
Change+$0.33 (+13.64%)
Volume$566
Capitalization50.66M
Kura Oncology
Price$6.71
Change+$0.15 (+2.28%)
Volume$800
Capitalization568.8M
ADVM vs KURA Comparison Chart
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. KURA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Buy and KURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ADVM: $2.42 vs. KURA: $6.57)
Brand notoriety: ADVM and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 23% vs. KURA: 62%
Market capitalization -- ADVM: $50.66M vs. KURA: $568.8M
ADVM [@Biotechnology] is valued at $50.66M. KURA’s [@Biotechnology] market capitalization is $568.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADVM and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 5 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • ADVM’s TA Score: 5 bullish, 3 bearish.
  • KURA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ADVM and KURA are a good buy in the short-term.

Price Growth

ADVM (@Biotechnology) experienced а +7.30% price change this week, while KURA (@Biotechnology) price change was +12.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($569M) has a higher market cap than ADVM($50.7M). KURA YTD gains are higher at: -24.569 vs. ADVM (-48.073). ADVM has higher annual earnings (EBITDA): -99.25M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. ADVM (153M). KURA has less debt than ADVM: KURA (19.4M) vs ADVM (73.3M). KURA has higher revenues than ADVM: KURA (68M) vs ADVM (1M).
ADVMKURAADVM / KURA
Capitalization50.7M569M9%
EBITDA-99.25M-177.18M56%
Gain YTD-48.073-24.569196%
P/E RatioN/AN/A-
Revenue1M68M1%
Total Cash153M658M23%
Total Debt73.3M19.4M378%
FUNDAMENTALS RATINGS
ADVM vs KURA: Fundamental Ratings
ADVM
KURA
OUTLOOK RATING
1..100
211
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
9688
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (27) in the Biotechnology industry is in the same range as ADVM (40). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ADVM (100). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's SMR Rating (92) in the Biotechnology industry is in the same range as ADVM (95). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's Price Growth Rating (88) in the Biotechnology industry is in the same range as ADVM (96). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ADVM (100). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMKURA
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDFVX15.33N/A
N/A
Lord Abbett Fundamental Equity A
AMTZX9.45N/A
N/A
AB All Market Real Return Z
PJFPX71.00N/A
N/A
PGIM Jennison Growth R4
MXMSX10.48N/A
N/A
Empower Small Cap Growth Instl
LZCOX9.36-0.04
-0.43%
Lazard US Small Cap Equity Select Open

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.86%
PYXS - KURA
65%
Loosely correlated
-3.52%
ZYME - KURA
44%
Loosely correlated
-0.57%
KYMR - KURA
44%
Loosely correlated
+7.68%
ADVM - KURA
44%
Loosely correlated
-1.82%
AXON - KURA
41%
Loosely correlated
+1.08%
More